Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com ...

From using infants gut bacteria to protect adults from cancer, to growing rice on the ocean's surface and non-browning bananas - Norwich ...

Scientific advancements in medicine, agriculture and environmental science play a crucial role in offering solutions to ...

In addition, Augustine today announced the founding of a Copenhagen, Denmark based subsidiary, Augustine Therapeutics Denmark ApS, which will serve as the company's hub for research related to ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Healthcare Patent Filing Outsourcing Market, revealing compelling growth prospects over the next decade. According to the ...

In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...

Beyond the heart, the study hints that other transplantable organs could benefit from improved cold storage methods using a simple diuretic.

BioNTech said it plans to invest up to 1 billion pounds ($1.34 billion) over the next 10 years to expand its research and development activities for innovative medicines in the U.K.